Abstract
Language | English |
---|---|
Pages | 1785-2002 |
Number of pages | 17 |
Journal | Chemical Society Reviews |
Volume | 45 |
Issue number | 7 |
Early online date | 27 Nov 2015 |
DOIs | |
Publication status | E-pub ahead of print - 27 Nov 2015 |
Fingerprint
Keywords
- vibrational spectroscop
- biofluids
- diseased tissue
- diagnostics
Cite this
}
Developing and understanding biofluid vibrational spectroscopy : a critical review. / Baker, Matthew J.; Hussain, Shawn R.; Lovergne, Lila; Untereiner, Valérie; Hughes, Caryn; Lukaszewski, Roman A.; Thiéfin, Gérard; Sockalingum, Ganesh D.
In: Chemical Society Reviews, Vol. 45, No. 7, 27.11.2015, p. 1785-2002.Research output: Contribution to journal › Article
TY - JOUR
T1 - Developing and understanding biofluid vibrational spectroscopy
T2 - Chemical Society Reviews
AU - Baker, Matthew J.
AU - Hussain, Shawn R.
AU - Lovergne, Lila
AU - Untereiner, Valérie
AU - Hughes, Caryn
AU - Lukaszewski, Roman A.
AU - Thiéfin, Gérard
AU - Sockalingum, Ganesh D.
PY - 2015/11/27
Y1 - 2015/11/27
N2 - Vibrational spectroscopy can provide rapid, label-free, and objective analysis for the clinical domain. Spectroscopic analysis of biofluids such as blood components (e.g. serum and plasma) and others in the proximity of the diseased tissue or cell (e.g. bile, urine, and sputum) offers non-invasive diagnostic/monitoring possibilities for future healthcare that are capable of rapid diagnosis of diseases via specific spectral markers or signatures. Biofluids offer an ideal diagnostic medium due to their ease and low cost of collection and daily use in clinical biology. Due to the low risk and in vasiveness of their collection they are widely welcomed by patients as a diagnostic medium. This review under scores recent research within the field of biofluid spectroscopy and its use in myriad pat hologies such as cancer and infectious diseases. It highlights current progresses, advents, and pitfalls within the field and discusses future spectroscopic clinical potentials for diagnostics. The requirements and issues surrounding clinical translation are also considered.
AB - Vibrational spectroscopy can provide rapid, label-free, and objective analysis for the clinical domain. Spectroscopic analysis of biofluids such as blood components (e.g. serum and plasma) and others in the proximity of the diseased tissue or cell (e.g. bile, urine, and sputum) offers non-invasive diagnostic/monitoring possibilities for future healthcare that are capable of rapid diagnosis of diseases via specific spectral markers or signatures. Biofluids offer an ideal diagnostic medium due to their ease and low cost of collection and daily use in clinical biology. Due to the low risk and in vasiveness of their collection they are widely welcomed by patients as a diagnostic medium. This review under scores recent research within the field of biofluid spectroscopy and its use in myriad pat hologies such as cancer and infectious diseases. It highlights current progresses, advents, and pitfalls within the field and discusses future spectroscopic clinical potentials for diagnostics. The requirements and issues surrounding clinical translation are also considered.
KW - vibrational spectroscop
KW - biofluids
KW - diseased tissue
KW - diagnostics
UR - http://pubs.rsc.org/en/content/articlelanding/2016/cs/c5cs00585j#!divAbstract
U2 - 10.1039/C5CS00585J
DO - 10.1039/C5CS00585J
M3 - Article
VL - 45
SP - 1785
EP - 2002
JO - Chemical Society Reviews
JF - Chemical Society Reviews
SN - 0306-0012
IS - 7
ER -